Proteomic biomarkers and pathway analysis for progression to heart failure in three epidemiological representative cohorts.
Fiche publication
Date publication
octobre 2024
Journal
European journal of heart failure
Auteurs
Membres identifiés du Cancéropôle Est :
Pr ROSSIGNOL Patrick
Tous les auteurs :
Dieden A, Girerd N, Ottosson F, Molvin J, Pareek M, Melander O, Bachus E, Råstam L, Lindblad U, Daka B, Leósdóttir M, Nilsson PM, Olsen MH, Clark AL, Cleland JGF, Delles C, González A, Lamiral Z, Duarte K, Rossignol P, Zannad F, Gudmundsson P, Jujić A, Magnusson M
Lien Pubmed
Résumé
Biomarkers associated with asymptomatic ventricular dysfunction might improve risk stratification and identify pathways leading to heart failure (HF). We explored the association between proteomic biomarkers and left ventricular hypertrophy (LVH), diastolic dysfunction (DD) and incident HF in three population-based cohorts.
Mots clés
Diastolic dysfunction, Heart failure, Left ventricular hypertrophy, Proteomics
Référence
Eur J Heart Fail. 2024 10 28;: